All stock lists
Bicara Therapeutics Inc. (NASDAQ:BCAX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
16.82-0.25 (-1.46%)
Insider Score
––Not scored
BCAX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BCAX analyst forecast
BCAX analyst consensus
No analyst ratings in the last 3 months.
BCAX 12-month price target
$41.00+142.6% upsideaverage of 1 firm
$41.00High
$41.00Low
Best analysts covering BCAX
No firm covering BCAX has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BCAX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Morgan Stanley | — | $41.00 | +134.7% | — | 2026-10-20 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.